Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Molecular Flow Simulations

K-Number: K201435 · 2021-12-03

Decision Date2021-12-03
Product CodeHAW
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Molecular Flow Simulations is a medical device manufactured by Therataxis, LLC. It received FDA 510(k) clearance on 2021-12-03 under approval number K201435. The device is classified under product code HAW. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Molecular Flow Simulations?

Molecular Flow Simulations is a medical device that received FDA 510(k) clearance on 2021-12-03. It is manufactured by Therataxis, LLC. The 510(k) number is K201435.

When was Molecular Flow Simulations approved by the FDA?

Molecular Flow Simulations received FDA 510(k) clearance on 2021-12-03, under approval number K201435.

What company makes Molecular Flow Simulations?

Molecular Flow Simulations is manufactured by Therataxis, LLC.

What is the FDA product code for Molecular Flow Simulations?

The FDA product code for Molecular Flow Simulations is HAW.

Related Devices (Code: HAW)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.